Abstract
A prospective study was designed to evaluate the prevalence and determinants of glucose metabolism abnormalities (GMAs) among HIV-1-infected pregnant women receiving highly active antiretroviral therapy (HAART).
| Original language | English |
|---|---|
| Pages (from-to) | 403-412 |
| Number of pages | 10 |
| Journal | HIV Clinical Trials |
| Volume | 10 |
| DOIs | |
| Publication status | Published - 2010 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Adolescent
- Adult
- Antiretroviral Therapy, Highly Active
- Diabetes, Gestational
- Female
- Glucose Intolerance
- Glucose Tolerance Test
- HIV Infections
- HIV Protease Inhibitors
- HIV-1
- Hepacivirus
- Hepatitis C
- Humans
- Nevirapine
- Pregnancy
- Pregnancy Complications, Infectious
- Prevalence
- Prospective Studies
- Risk Factors
Fingerprint
Dive into the research topics of 'Effect of HCV infection on glucose metabolism in pregnant women with HIV receiving HAART'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver